July 7, 2016
"In elderly patients with type 2 diabetes, mild cognitive impairment may be independently associated with increased DPP-IV activities, according to study findings published in Diabetes Care."
Click here to read the full article
January 25, 2016
"Men with well-controlled type 2 diabetes treated with metformin saw reduced postprandial glucose levels when combining the DPP-IV inhibitor vildagliptin with a whey protein preload as add-on therapy, according to research inDiabetes Care."
Click here to read the ful...
A new utility of glycated albumin in monitoring cardiovascular autonomic neuropathy (CAN) in type 2 diabetic patients
October 17, 2017
Epinex’s Research Paper Reaches New Milestone
August 25, 2017
Epinex at the 2017 AACC Conference
August 18, 2017
Beyond A1C: Glycated Albumin Takes Center Stage at 2017 AACC Symposium in San Diego
July 31, 2017
Amidst Healthcare Chaos, California Authorizes a New Bill for Diabetes Prevention
July 20, 2017
A new article in JAMA reports self-blood glucose monitoring for type 2 diabetes is not necessary.
Is there an alternativ...
December 18, 2018
Plug and Play Tech Center
August 21, 2018
Asad Zaidi CEO of Epinex Diagnostic Inc. will attend LIGHT Forum 2018, a prestigious gathering of prominent leaders in...
May 4, 2018
Glycated Albumin used in measuring ‘Stress Diabetes’
November 17, 2017
A potential role of glycated albumin as a marker for inflammation
October 18, 2017